Lawrence P. Wennogle

3.3k total citations
69 papers, 2.6k citations indexed

About

Lawrence P. Wennogle is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Lawrence P. Wennogle has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 9 papers in Pharmacology. Recurrent topics in Lawrence P. Wennogle's work include Receptor Mechanisms and Signaling (16 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Neuropeptides and Animal Physiology (7 papers). Lawrence P. Wennogle is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Neuropeptides and Animal Physiology (7 papers). Lawrence P. Wennogle collaborates with scholars based in United States, Switzerland and Netherlands. Lawrence P. Wennogle's co-authors include Laurence R. Meyerson, Jean‐Pierre Changeux, Joseph P. Hendrick, Tsunao Saitoh, Anton Yuryev, Justin Ansell, Bernard Beer, Robert E. Oswald, William J. Netzer and Peng Li and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

Lawrence P. Wennogle

69 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence P. Wennogle United States 30 1.7k 761 404 316 208 69 2.6k
Samuel J. Strada United States 31 1.7k 1.0× 520 0.7× 240 0.6× 512 1.6× 111 0.5× 90 2.5k
Ethan S. Burstein United States 32 1.9k 1.2× 1.3k 1.7× 258 0.6× 288 0.9× 243 1.2× 91 3.1k
Matthew A. Sills United States 29 1.7k 1.1× 1.4k 1.8× 219 0.5× 351 1.1× 116 0.6× 72 3.0k
G. Gaviraghi Italy 24 1.3k 0.8× 574 0.8× 207 0.5× 438 1.4× 67 0.3× 94 2.4k
Clay W. Scott United States 31 1.9k 1.1× 733 1.0× 273 0.7× 941 3.0× 70 0.3× 63 3.2k
Hagit Eldar-Finkelman Israel 41 3.5k 2.1× 699 0.9× 382 0.9× 1.0k 3.2× 147 0.7× 83 5.3k
Petrus J. Pauwels France 33 2.0k 1.2× 1.9k 2.4× 206 0.5× 468 1.5× 223 1.1× 111 3.2k
Vincent Setola United States 33 2.8k 1.7× 1.8k 2.3× 676 1.7× 290 0.9× 146 0.7× 81 5.1k
Anton D. Michel United Kingdom 28 1.3k 0.8× 917 1.2× 227 0.6× 594 1.9× 221 1.1× 55 2.6k
Richard W. Ransom United States 29 2.4k 1.5× 1.9k 2.5× 291 0.7× 293 0.9× 99 0.5× 73 4.4k

Countries citing papers authored by Lawrence P. Wennogle

Since Specialization
Citations

This map shows the geographic impact of Lawrence P. Wennogle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence P. Wennogle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence P. Wennogle more than expected).

Fields of papers citing papers by Lawrence P. Wennogle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence P. Wennogle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence P. Wennogle. The network helps show where Lawrence P. Wennogle may publish in the future.

Co-authorship network of co-authors of Lawrence P. Wennogle

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence P. Wennogle. A scholar is included among the top collaborators of Lawrence P. Wennogle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence P. Wennogle. Lawrence P. Wennogle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Netzer, William J., et al.. (2017). Nose-to-brain transport of imatinib mesylate: A pharmacokinetic evaluation. European Journal of Pharmaceutical Sciences. 102. 46–54. 27 indexed citations
2.
Wennogle, Lawrence P., et al.. (2017). Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction. Advances in neurobiology. 17. 349–384. 22 indexed citations
3.
Snyder, Gretchen L., Jos Prickaerts, Lei Zhang, et al.. (2016). Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats. Psychopharmacology. 233(17). 3113–3124. 49 indexed citations
4.
Wennogle, Lawrence P., Gretchen L. Snyder, Peng Li, et al.. (2010). ENHANCEMENT OF COGNITION IN SCHIZOPHRENIA VIA INHIBITION OF PHOSPHODIESTERASE-1B AND POTENTIATION OF DOPAMINE D1 RECEPTOR SIGNALING. Schizophrenia Research. 117(2-3). 489–489. 1 indexed citations
5.
He, Gen, Wenjie Luo, Peng Li, et al.. (2010). Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease. Nature. 467(7311). 95–98. 263 indexed citations
6.
Zhu, Hongwen, Jennifer OʼBrien, James P. O’Callaghan, et al.. (2010). Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain. Brain Research. 1342. 11–23. 18 indexed citations
7.
Yuryev, Anton & Lawrence P. Wennogle. (2003). Novel raf kinase protein–protein interactions found by an exhaustive yeast two-hybrid analysis. Genomics. 81(2). 112–125. 37 indexed citations
8.
Hansen, Barbara C., et al.. (1999). The metabolic syndrome X : convergence of insulin resistance, glucose intolerance, hypertension, obesity, and dyslipidemias- searching for the underlying defects. New York Academy of Sciences eBooks. 8 indexed citations
9.
Pellas, Theodore C., William C. Boyar, Jan van Oostrum, et al.. (1998). Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo. The Journal of Immunology. 160(11). 5616–5621. 42 indexed citations
10.
Zhang, Xiaolu, William C. Boyar, Matthew J. Toth, Lawrence P. Wennogle, & Nina C. Gonnella. (1997). Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy. Proteins Structure Function and Bioinformatics. 28(2). 261–267. 66 indexed citations
11.
Priestle, J.P., et al.. (1997). Characterization, crystallization and preliminary crystallographic analysis of human recombinant cyclooxygenase-2. Acta Crystallographica Section D Biological Crystallography. 53(2). 224–226. 2 indexed citations
12.
Wennogle, Lawrence P., et al.. (1994). Stabilization of C5a receptor–G‐protein interactions through ligand binding. Journal of Cellular Biochemistry. 55(3). 380–388. 9 indexed citations
13.
Janero, David R., et al.. (1993). Radioiodination of transforming growth factor-β (TGF-β) in a modified Bolton-Hunter reaction system. Journal of Biochemical and Biophysical Methods. 26(4). 343–350. 3 indexed citations
14.
Braunwalder, Albert, Nicholas G. Galakatos, John Rediske, et al.. (1992). Characterization of the binding of bolton-hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes. Molecular Immunology. 29(11). 1319–1324. 11 indexed citations
15.
Seidah, Nabil G., et al.. (1989). Substrate phosphorylation can inhibit proteolysis by trypsin-like enzymes. Archives of Biochemistry and Biophysics. 272(2). 274–280. 46 indexed citations
16.
Jones, Barry, Paul P. Tamburini, Angelo P. Consalvo, et al.. (1988). A fluorometric assay for peptidyl α-amidation activity using high-performance liquid chromatography. Analytical Biochemistry. 168(2). 272–279. 36 indexed citations
17.
Wennogle, Lawrence P., et al.. (1988). Profiling of inhibitors of protein kinase C. Advances in Enzyme Regulation. 27. 277–293. 8 indexed citations
18.
Tamburini, Paul P., Barry Jones, Angelo P. Consalvo, et al.. (1988). Structure-activity relationships for glycine-extended peptides and the α-amidating enzyme derived from medullary thyroid CA-77 cells. Archives of Biochemistry and Biophysics. 267(2). 623–631. 26 indexed citations
19.
Wennogle, Lawrence P. & Laurence R. Meyerson. (1982). Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites. European Journal of Pharmacology. 86(2). 303–307. 107 indexed citations
20.
Saitoh, Tsunao, Lawrence P. Wennogle, & Jean‐Pierre Changeux. (1979). Factors regulating the susceptibility of the acetylcholine receptor protein to heat inactivation. FEBS Letters. 108(2). 489–494. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel J. Strada Breakdown of academic impact, for papers by Ethan S. Burstein Breakdown of academic impact, for papers by Matthew A. Sills Breakdown of academic impact, for papers by G. Gaviraghi Breakdown of academic impact, for papers by Clay W. Scott Breakdown of academic impact, for papers by Hagit Eldar-Finkelman Breakdown of academic impact, for papers by Petrus J. Pauwels Breakdown of academic impact, for papers by Vincent Setola Breakdown of academic impact, for papers by Anton D. Michel Breakdown of academic impact, for papers by Richard W. Ransom
Rankless by CCL
2026